C12N 2760/18321
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2760/18321 (Viruses as such) appears on 23 US grants and 32 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 32
- Assignees
- 17
- Inventors
- 39
- Latest grant
- 18 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 3 |
| 2005 | 1 | 4 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 2 | 3 |
| 2010 | 1 | 2 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 3 | 2 |
| 2015 | 1 | 1 |
| 2016 | 2 | 2 |
| 2017 | 4 | 2 |
| 2018 | 2 | 3 |
| 2019 | 3 | 1 |
| 2020 | 0 | 3 |
| 2021 | 1 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
By publication year.
Recent patents
- Methods and compositions for treating negative-sense single-stranded RNA virus18 Feb 2025US 12,227,769 B2Nationwide Children's Hospital, Inc.
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences11 Jan 2022US 11,220,718 B2Erasmus University Medical Center Rotterdam
- Virus causing respiratory tract illness in susceptible mammals2 Nov 2021US 11,162,148 B2Erasmus University Medical Center Rotterdam
- Virus causing respiratory tract illness in susceptible mammals31 Dec 2019US 10,519,517 B2Erasmus University Medical Center
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences14 May 2019US 10,287,640 B2Erasmus University Medical Center Rotterdam
- Methods and compositions for treating negative-sense single-stranded rna virus7 Aug 2025US 2025/0250548 A1Nationwide Children's Hospital, Inc.
- Vaccine composition against two respiratory viruses19 Jun 2025US 2025/0195637 A1
- Methods and compositions for treating negative-sense single-stranded rna virus3 Feb 2022US 2022/0033783 A1Nationwide Children's Hospital, Inc.
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences24 Dec 2020US 2020/0399718 A1Erasmus University Medical Center Rotterdam
- Virus causing respiratory tract illness in susceptible mammals7 May 2020US 2020/0140964 A1Erasmus University Medical Center Rotterdam
Most cited
By later US patents
- Metapneumovirus strains and their use in vaccine formulations and sequences74US 8,722,341 B2MedImmune Vaccines, Inc. · 2014
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences35US 7,531,342 B2MedImmune, LLC · 2009
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences30US 7,449,324 B2MedImmune, LLC · 2008
- Virus causing respiratory tract illness in susceptible mammals29US 8,927,206 B2ViroNovative BV · 2015
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus27US 7,704,720 B2MedImmune, LLC · 2010